Antimicrobial effect of salicylamide derivatives against
intestinal sulfate-reducing bacteria

J 2016

Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria

KUSHKEVYCH, Ivan, Petr KOLLÁR, Ana Luísa FERREIRA a Diogo PALMA

Základní údaje

Originální název

Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria

Autoři

KUSHKEVYCH, Ivan, Petr KOLLÁR, Ana Luísa FERREIRA a Diogo PALMA

Vydání

Journal of Applied Biomedicine, 2016, 1214-021X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10600 1.6 Biological sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.433

Organizační jednotka

Přírodovědecká fakulta

DOI

http://dx.doi.org/10.1016/j.jab.2016.01.005

UT WoS

000373608500007

Klíčová slova anglicky

Sulfate-reducing bacteria; Desulfovibrio piger; Desulfomicrobium sp.; Salicylamides; Bowel disease; Lipophilicity; Structure–activity relationships

Štítky

Změněno: 13. 4. 2018 10:43, Ing. Nicole Zrilić

Anotace

V originále

Sulfate-reducing bacteria (SRB) are most likely involved in both the initiation and maintenance of inflammatory bowel disease (IBD); unfortunately present antibacterial chemotherapeutics used in the treatment of IBD have been ineffective. Thus, the antimicrobial activity of salicylamide derivatives against two different genera of intestinal SRB, Desulfovibrio and Desulfomicrobium, was investigated. Six 2-(phenylcarbamoyl)phenyl N-[(benzyloxy)carbonyl]alkanoates and three 2-hydroxy-N-[(2S)-1-oxo-1-(phenylamino)alkan-2-yl]benzamides showed MIC values in the range from 0.22 to 0.35 microM against Desulfovibrio piger Vib-7 and in the range from 0.27 to 8.52 microM against Desulfomicrobium sp. Rod-9, while MIC values of ciprofloxacin were 41.2 microM and 39.3 microM. The highest potency against the two strains was observed for 4-chloro-N-{(2S)-1-[(3,4-dichlorophenyl)amino]-3-methyl-1-oxobutan-2-yl}-2-hydroxybenzamide (MIC 0.22 microM and 0.27 microM). 4-Chloro-2-[(4-nitrophenyl)carbamoyl]phenyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoate showed high activity against D. piger Vib-7 (MIC = 0.26 microM), while 4-chloro-2-[(4-methylphenyl)carbamoyl]phenyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-2-yl)propanoate expressed high activity against Desulfomicrobium sp. Rod-9 (MIC = 0.31 microM). Structure–activity relationships are discussed.

Citovat

KUSHKEVYCH, Ivan, Petr KOLLÁR, Ana Luísa FERREIRA a Diogo PALMA. Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria. Journal of Applied Biomedicine. 2016, roč. 2016, 14(2), s. 125-130. ISSN 1214-021X. Dostupné z: https://dx.doi.org/10.1016/j.jab.2016.01.005.

@article{1377001,
   author = {Kushkevych, Ivan and Kollár, Petr and Ferreira, Ana Luísa and Palma, Diogo},
   article_number = {14(2)},
   doi = {http://dx.doi.org/10.1016/j.jab.2016.01.005},
   keywords = {Sulfate-reducing bacteria; Desulfovibrio piger; Desulfomicrobium sp.; Salicylamides; Bowel disease; Lipophilicity; Structure–activity relationships},
   language = {eng},
   issn = {1214-021X},
   journal = {Journal of Applied Biomedicine},
   note = {doc. Kushkevych nemá na WoS afiliaci na MU, nýbrž na Univer. veterinárního lékařství. Nelze přenášet do RIV bez domácího autora!},
   title = {Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria},
   url = {http://dx.doi.org/10.1016/j.jab.2016.01.005},
   volume = {2016},
   year = {2016}
}

TY  - JOUR
ID  - 1377001
AU  - Kushkevych, Ivan - Kollár, Petr - Ferreira, Ana Luísa - Palma, Diogo
PY  - 2016
TI  - Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria
JF  - Journal of Applied Biomedicine
VL  - 2016
IS  - 14(2)
SP  - 125-130
EP  - 125-130
SN  - 1214021X
N1  - doc. Kushkevych nemá na WoS afiliaci na MU, nýbrž na Univer. veterinárního lékařství. Nelze přenášet do RIV bez domácího autora!
KW  - Sulfate-reducing bacteria
KW  - Desulfovibrio piger
KW  - Desulfomicrobium sp.
KW  - Salicylamides
KW  - Bowel disease
KW  - Lipophilicity
KW  - Structure–activity relationships
UR  - http://dx.doi.org/10.1016/j.jab.2016.01.005
L2  - http://dx.doi.org/10.1016/j.jab.2016.01.005
N2  - Sulfate-reducing bacteria (SRB) are most likely involved in both the initiation and maintenance of inflammatory bowel disease (IBD); unfortunately present antibacterial chemotherapeutics used in the treatment of IBD have been ineffective. Thus, the antimicrobial activity of salicylamide derivatives against two different genera of intestinal SRB, Desulfovibrio and Desulfomicrobium, was investigated. Six 2-(phenylcarbamoyl)phenyl N-[(benzyloxy)carbonyl]alkanoates and three 2-hydroxy-N-[(2S)-1-oxo-1-(phenylamino)alkan-2-yl]benzamides showed MIC values in the range from 0.22 to 0.35 microM against Desulfovibrio piger Vib-7 and in the range from 0.27 to 8.52 microM against Desulfomicrobium sp. Rod-9, while MIC values of ciprofloxacin were 41.2 microM and 39.3 microM. The highest potency against the two strains was observed for 4-chloro-N-{(2S)-1-[(3,4-dichlorophenyl)amino]-3-methyl-1-oxobutan-2-yl}-2-hydroxybenzamide (MIC 0.22 microM and 0.27 microM). 4-Chloro-2-[(4-nitrophenyl)carbamoyl]phenyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoate showed high activity against D. piger Vib-7 (MIC = 0.26 microM), while 4-chloro-2-[(4-methylphenyl)carbamoyl]phenyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-2-yl)propanoate expressed high activity against Desulfomicrobium sp. Rod-9 (MIC = 0.31 microM). Structure–activity relationships are discussed.
ER  -

KUSHKEVYCH, Ivan, Petr KOLLÁR, Ana Luísa FERREIRA a Diogo PALMA. Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria. \textit{Journal of Applied Biomedicine}. 2016, roč.~2016, 14(2), s.~125-130. ISSN~1214-021X. Dostupné z: https://dx.doi.org/10.1016/j.jab.2016.01.005.

Podrobný výpis o publikaci